PHAT NASDAQ
Phathom Pharmaceuticals, Inc.
1W: -5.2%
1M: -25.3%
3M: -39.2%
YTD: -56.0%
1Y: -43.7%
3Y: -32.9%
5Y: -78.3%
$6.92
-0.16 (-2.26%)
Weekly Expected Move ±9.0%
$6
$6
$7
$8
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-07-08
Earliest Filing
2022-11-01
Latest Filing
investor: 4
supplier: 2
Counterparties (Filed by PHAT)
6 relationshipsCompanies named in PHAT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| NovaQuest Capital Management | — | investor | Entity managing or advising Initial Investors in Revenue Interest Financing Agreement | 2022-11-01 | View |
| Sagard Holdings Manager LP | — | investor | Entity managing or advising Initial Investors in Revenue Interest Financing Agreement | 2022-11-01 | View |
| Hercules Capital, Inc. | HCXY | investor | Initial Investor and Administrative/Collateral Agent in Revenue Interest Financing Agreement | 2022-11-01 | View |
| CO Finance LVS XXXVII LLC | — | investor | Additional Investor joining Revenue Interest Financing Agreement | 2022-11-01 | View |
| Evonik Operations GmbH | — | supplier | Agreement to supply commercial quantities of vonoprazan drug substance (API) to Phathom Pharmaceuticals, Inc. | 2022-08-04 | View |
| Catalent Pharma Solutions, LLC | — | supplier | Agreement to supply commercial quantities of vonoprazan fumarate tablets to Phathom Pharmaceuticals, Inc. | 2021-07-08 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-29 | Other Events | View | |
| 2026-07-30 | Earnings Release; Exhibits | View | |
| 2026-06-23 | Other Events | View | |
| 2026-05-21 | Shareholder Vote | View | |
| 2026-04-30 | Earnings Release; Exhibits | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-08 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-04 | Other Events | View | |
| 2025-10-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-27 | Other Events | View | |
| 2025-10-06 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-16 | Other Events | View | |
| 2025-06-09 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-06 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-05-01 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-16 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-04-01 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-03-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR